NCT02695277 - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation | Biotech Hunter

Enrollment

146

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2022

Study Completion Date

September 30, 2024

Conditions

Atrial FibrillationPersistent and Longstanding Persistent Atrial Fibrillation

Interventions

DEVICE

AtriCure Bipolar System

DEVICE

Standard Endocardial Ablation with Catheter

DEVICE

AtriClip® PRO LAA Exclusion System

DEVICE

Endocardial Ablation with Catheter

DEVICE

Repeated Endocardial ablation(s)

Trial Locations (12)

Dr Tomáš Ostřížek, Brno

Czech Budejovice Hospital, Inc., České Budějovice

Cardiovascular Center Bad Neustadt, Bad Neustadt an der Saale

Schüchtermann-Schiller'sche Kliniken Herzzentrum Osnabrück, Bad Rothenfelde

Heart Center Leipzig, Leipzig

Klinikum Ludwigsburg, Ludwigsburg

Peter Osypka Heart Center Munich, Munich

Kliniken Sindelfingen, Sindelfingen

Sana Heart Center Stuttgart, Stuttgart

St. Antonius Hospital, Nieuwegein

Central Clinical Hospital of the Ministry of Interior, Warsaw

Northern General Hospital, Sheffield